The Westmark laboratory at the University of Wisconsin-Madison is conducting a survey to learn about associations between infant feeding and neurodevelopment in children with Fragile X syndrome (FXS).
About the Study
Who can participate?
Caregivers of individuals with full mutation Fragile X syndrome (FXS). The individuals with Fragile X may be any age and male or female. You must read English fluently.
What will happen in the study?
If you decide to be in this research study, you will complete an anonymous online survey. The survey should take about 20 minutes to finish.
You can choose not to answer any questions you choose. You can also choose to stop taking the survey at any time. The survey must be completed in one sitting.
All survey data will be kept on a secure, password protected server on the campus of the University of Wisconsin-Madison. Only individuals directly involved in the research study will have access to the data.
What are the good things that can happen from this research?
There are no direct benefits to you or your child.
You will be contributing to the body of knowledge about early development in Fragile X. Data from this study could help provide critical information regarding the relationship between certain types of infant feeding and the development of more severe phenotypes in Fragile X.
The results will be published and could inform public policy on newborn screening for Fragile X if an early-life nutritional intervention were available.
What are the bad things that can happen from this research?
There are minimal risks in participating in this survey. Your time in answering the survey questions could be a burden.
There may be other risks that we do not know about yet.
Will I or my child be paid to complete this study?
No, there is no compensation for completing this survey.
Interested in Participating?
Our Most Recent Opportunities
Study: Language Study for Children and Adolescents with Fragile X syndrome
Researchers at the University of Wisconsin-Madison and the University of Massachusetts-Amherst are conducting a study to learn about links between learning and language in Fragile X syndrome.
Survey: Fragile X Nutrition Survey
The University of Wisconsin-Madison is conducting a survey to learn about associations between infant feeding and neurodevelopment in children with Fragile X syndrome.
Clinical Trial: Phase 2B/3 Studies of BPN14770 in Fragile X syndrome
Tetra Therapeutics is conducting a two randomized, placebo-controlled studies of BPN14770/zatolmilast to learn about the experimental drug’s safety and efficacy for males ages 12-45.
IMPACT-FXS: Investigating Multiple Pathways And Combined Treatments for FXS
Healx is conducting a Phase 2, placebo-controlled study in adolescent and adult males with fragile X syndrome (FXS). The purpose of this study is to confirm whether Healx's drug candidates are safe and work as intended to reduce symptoms of FXS.
Survey: Developing a Gold Standard for Tracking Adult Functional Outcomes in Developmental Disabilities (AFS Study)
University of Pittsburgh is conducting this research to develop the Adult Functioning Scale (AFS), a new survey being designed to capture outcomes in the areas of social functioning, employment, independence, and satisfaction for individuals with various developmental disorders.
Study: Aging in Toolbox
Researchers around the country are conducting a study to better understand cognitive profiles in adults with intellectual disability. This study is an extension of the ongoing Toolbox Study, which is aimed to optimize cognitive assessment tools for children and young adults with intellectual disabilities.